Vector Science and Therapeutics Corp. shares experience notable declines this week amid a lack of major news.
This week, Vector Science and Therapeutics Corp. (PAIN.V) saw its stock price decline by 12.43%, closing at C$1.57, down 6.06% on the day. Despite a strong year-to-date performance of 219.59%, the recent price action raises questions for investors.
Advertisement
Vector Science and Therapeutics Corp.
PAIN.V
PAIN.V
Vector Science and Therapeutics Corp.
WealthAwesomeMarket cap
$258.00M
52W high
$2.65
52W low
$0.35
1W change
-12.43%
Beta
4.76
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PAIN's historical volatility
30-Day Vol
86.3%
Annualized
90-Day Vol
95.5%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.30
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.46 | C$1.08 – C$1.97 |
| 60 trading days | C$1.38 | C$0.90 – C$2.10 |
| 90 trading days | C$1.30 | C$0.77 – C$2.17 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: With no significant news to drive the recent decline, investors may want to keep an eye on technical indicators and trading volume for potential signals moving forward.
Vector Science and Therapeutics Corp. Stock Down 12.43% This Week.
Over the past week, the stock has significantly underperformed, moving away from its 50-day moving average of C$1.86.
Bull case
The company’s strong year-to-date performance indicates it could recover, especially if market conditions improve or new developments come to light.
Bear case
The recent downturn, coupled with negative fundamentals like a high beta and poor profit margins, suggests ongoing volatility and risk for investors.
Recent Price Action
Advertisement
Vector Science and Therapeutics Corp. (PAIN.V) closed at C$1.57, down 6.06% for the day and 12.43% for the week. Despite a remarkable year-to-date gain of 219.59%, the stock has faced downward pressure recently, raising concerns among investors.
Technical Picture
Currently, the stock is trading below both its 50-day moving average of C$1.86 and its 200-day moving average of C$1.73, indicating a bearish trend. The stock has a 52-week range of C$0.35 to C$2.65, currently sitting at approximately 53% of this range. With a beta of 4.76, the stock shows significant volatility, which may deter risk-averse investors. Recent trading volume was 3,337 shares, which is 1.18 times the 20-day average volume of 110,170 shares, suggesting increased interest despite the price decline.
Insider Activity
There is no recent insider activity reported for Vector Science and Therapeutics Corp., leaving investors without additional insights into potential changes in ownership or confidence in the company's future.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
